- 【Updated on May 12, 2025】 Integration of CiNii Dissertations and CiNii Books into CiNii Research
- Trial version of CiNii Research Automatic Translation feature is available on CiNii Labs
- Suspension and deletion of data provided by Nikkei BP
- Regarding the recording of “Research Data” and “Evidence Data”
Relationship between proton pump inhibitor therapy and spontaneous bacterial peritonitis in cirrhotic patients with ascites
-
- Matsumoto Shuichi
- Department of Hepatology, Fukuoka Tokushukai Medical Center Department of General Internal Medicine, Fukuoka Tokushukai Medical Center
-
- Takizawa Naoho
- Department of General Internal Medicine, Fukuoka Tokushukai Medical Center
-
- Kaneyama Yasunari
- Department of General Internal Medicine, Fukuoka Tokushukai Medical Center
-
- Miyai Hitoki
- Department of General Internal Medicine, Fukuoka Tokushukai Medical Center
-
- Kodama Nobuhiro
- Department of General Internal Medicine, Fukuoka Tokushukai Medical Center
-
- Matsubayashi Sunao
- Department of Psycosomatic Medicine, Fukuoka Tokushukai Medical Center
Bibliographic Information
- Other Title
-
- 腹水を有する肝硬変患者におけるプロトンポンプ阻害薬と特発性細菌性腹膜炎の関連
- フクスイ オ ユウスル カンコウヘン カンジャ ニ オケル プロトンポンプ ソガイヤク ト トクハツセイ サイキンセイ フクマクエン ノ カンレン
Search this article
Description
Objective. To demonstrate the relationship between proton pump inhibitor (PPI) and spontaneous bacterial peritonitis (SBP) in cirrhotic patients with ascites. Material and Method. A total of 157 cirrhotic patients with ascites who underwent diagnostic paracentesis from January 2006 to October 2011 were included. SBP was defined as more than 250/mm3 polymorphonuclear leukocytes with or without a positive culture from the ascitec fluid. Result. 38 patients had SBP and 119 did not. On multivariate analysis, hepatocellular carcinoma (OR=5.09, 95% CI 2.09-13.05; p<0.01), MELD score (>=20, OR=3.57, 95% CI 1.40-9.69, p<0.01), PPI use (OR=2.60, 95% CI 1.13-6.12; p=0.02) were risk factor for SBP. Conclusion. PPI use, as well as with hepatocellular carcinoma and high MELD score, was an independent risk factor for the development of SBP in cirrhotic patients with ascites. We recommend that we should use carefully PPI to cirrhotic patients with ascites. Further prospective studies are warranted to clarify this issue.
Journal
-
- Kanzo
-
Kanzo 55 (9), 530-536, 2014
The Japan Society of Hepatology
- Tweet
Keywords
Details 詳細情報について
-
- CRID
- 1390282679771128064
-
- NII Article ID
- 130004695965
-
- NII Book ID
- AN00047770
-
- ISSN
- 18813593
- 04514203
-
- NDL BIB ID
- 025821924
-
- Text Lang
- ja
-
- Data Source
-
- JaLC
- NDL Search
- Crossref
- CiNii Articles
-
- Abstract License Flag
- Disallowed